A research team from Johns Hopkins Medicine and Johns Hopkins University has developed a machine-learning (ML) tool capable of predicting who has the highest probability of being naturally resistant to COVID-19 infection despite being exposed to SARS-CoV-2, the virus that causes it.
The study, published this week in PLOS One, aims to better understand the factors that influence COVID-19 resistance.
“If we can identify which people are naturally able to avoid infection by SARS-CoV-2, we may be able to learn — in addition to societal and behavioral factors — which genetic and environmental differences influence their defense against the virus,” said Karen (Kai-Wen) Yang, lead study author and a biomedical engineering graduate student in the Translational Informatics Research and Innovation Lab at Johns Hopkins University, in the press release. “That insight could lead to new preventive measures and more highly targeted treatments.”
To develop their model, the researchers gathered data from the Johns Hopkins COVID-19 Precision Medicine Analytics Platform Registry (JH-CROWN), which contains information for patients with a suspected or confirmed SARS-CoV-2 infection seen within the Johns Hopkins Health System, the press release states.
From this information, the research team selected patients who had received a COVID-19 test between June 10, 2020, and Dec. 15, 2020, and reported “potential exposure to the virus” as the reason for testing. Dec. 15 was chosen as the end date because it was just before large-scale COVID-19 vaccination efforts began in the US, which allowed researchers to avoid the confounding effects of vaccines, rather than natural resistance, on preventing COVID-19 infection.
The final cohort comprised 8,536 study participants who were divided into two groups: those who either did not share a household with any COVID-19 patients or whose household had 10 or more patients, and those who shared a residence with 10 or fewer people, with at least one being a COVID-19 patient.
The first group, consisting of 8,476 participants, served as the training and initial testing test, while the remaining 60 participants were grouped into a Household Index (HHI) Set, which served as a separate testing set.
EHR data from the cohort was analyzed using the Maximal-frequent All-confident pattern Selection Pattern-based Clustering (MASPC) algorithm, which combines patient demographic information, the relevant International Statistical Classification of Diseases and Related Health Problems (ICD) medical diagnostic codes, outpatient medication orders, and the number of comorbidities present for each patient.
“We hypothesized that MASPC would enable us to cluster patients with similar patterns in their data to define them as resistant and non-resistant to SARS-CoV-2, and with the hope that the algorithm would learn with each analysis how to improve the accuracy and reliability of future assignments,” explained co-senior study author Stuart Ray, MD, vice chair of medicine for data integrity and analytics, and professor of medicine at the Johns Hopkins University School of Medicine, in the press release. “This initial study using JH-CROWN data was conducted to give life to that hypothesis, a proof-of-concept trial of our statistical model to show that resistance to COVID-19 might be predictable based [on] a patient’s clinical and demographic profile.”
The researchers were able to identify 56 of these patterns, five of which captured who was most likely exposed to the virus.
“Looking for these patterns in HHI Set — the individuals most likely to have been exposed to SARS-CoV-2 in close quarters — and then statistically analyzing the results, our model’s best performance was 0.61,” says Ray. “Since a score of 0.5 shows only chance association between the prediction and reality, and 1 is 100% association, this shows the model has promise as a tool for identifying people with COVID-19 resistance who can be further studied.”
The researchers noted that the study has multiple limitations, such as potential bias from the self-reporting of COVID-19 exposure by participants, the small number of participants in the HHI group, the short timeframe of the study, and the possibility that participants may have taken tests for SARS-CoV-2 using home kits or at facilities outside the Johns Hopkins system, which would not have been recorded in the JH-CROWN database.

News
A potential milestone in cancer therapy
Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough in the fight against cancer. They identified a previously unknown weak point of prostate [...]
Cardiovascular Crystal Ball: New Tool Predicts Future Heart Disease Risk
Faculty members at the UM School of Medicine have created a cutting-edge tool that enables the early identification and assessment of risks in vulnerable patients. Heart disease, being the leading cause of death globally, [...]
Scientists analyze a single atom with X-rays for the first time
In the most powerful X-ray facilities in the world, scientists can analyze samples so small they contain only 10,000 atoms. Smaller sizes have proved exceedingly difficult to achieve, but a multi-institutional team has scaled [...]
AI Demonstrates Superior Performance in Predicting Breast Cancer
AI algorithms outperformed traditional clinical risk models in a large-scale study, predicting five-year breast cancer risk more accurately. These models use mammograms as the single data source, offering potential advantages in individualizing patient care [...]
Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer Formation
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during the transformation from pre-cancer to cancer, say Stanford Medicine-led team. Tiny circles of DNA that defy the accepted laws of [...]
Death to Blood Cancer Cells: New Drug Combination Could Revive the Power of Leading Treatment
Future clinical trials will be conducted to investigate whether the combination of chloroquine and venetoclax can prevent disease recurrence. Although new drugs have been developed to induce cancer cell death in individuals with acute [...]
Illuminating Science: X-Rays Visualize How One of Nature’s Strongest Bonds Breaks
Scientists have deciphered how an activated catalyst breaks down the strong carbon-hydrogen bonds in potent greenhouse gas methane, according to a study published in Science. Using advanced X-ray technology and quantum-chemical calculations, they tracked the [...]
Using magnetic nanoparticles as a rapid test for sepsis
Qun Ren, an Empa researcher, and her team are currently developing a diagnostic procedure that can rapidly detect life-threatening blood poisoning caused by staphylococcus bacteria. Staphylococcal sepsis is fatal in up to 40% of [...]
Team develops nanoparticles to deliver brain cancer treatment
University of Queensland researchers have developed a nanoparticle to take a chemotherapy drug into fast growing, aggressive brain tumors. Research team lead Dr. Taskeen Janjua from UQ's School of Pharmacy said the new silica [...]
Tumor Avatars – A New Approach to Personalized Cancer Treatment
A team from the University of Geneva (UNIGE) has devised a novel method for customizing treatments by testing them on artificial tumors. Determining the optimal treatment for colon cancer can be challenging as each [...]
STING Like a Bee: MIT’s Revolutionary Approach to Cancer Immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice. MIT researchers have engineered a therapeutic cancer vaccine that targets the STING pathway, vital for immune response [...]
AI Battles Superbugs: Helps Find New Antibiotic Drug To Combat Drug-Resistant Infections
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings. Using an artificial intelligence algorithm, researchers at MIT and McMaster University have identified a new antibiotic that can kill a [...]
Cancer and AI – Can ChatGPT Be Trusted?
A study published in the Journal of The National Cancer Institute Cancer Spectrum delved into the increasing use of chatbots and artificial intelligence (AI) in providing cancer-related information. The researchers discovered that these digital resources accurately [...]
Breathing New Life: Oxygen Therapy Improves Heart Function in Long COVID Patients
A small trial has found that hyperbaric oxygen therapy (HBOT) may help restore proper heart function in patients with post-COVID syndrome, with participants in the HBOT group experiencing a significant increase in global longitudinal [...]
Wireless Brain-Spine Interface: A Leap Towards Reversing Paralysis
Summary: In a pioneering study, researchers designed a wireless brain-spine interface enabling a paralyzed man to walk naturally again. The ‘digital bridge’ comprises two electronic implants — one on the brain and another on the [...]
New study reveals a gel that promises to wipe out brain cancer for good
An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that's never been accomplished by any drug or surgery. So what makes this gel so special? Scientists at Johns Hopkins University (JHU) have [...]